Your browser doesn't support javascript.
loading
Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy.
Abril-Rodriguez, Gabriel; Torrejon, Davis Y; Liu, Wei; Zaretsky, Jesse M; Nowicki, Theodore S; Tsoi, Jennifer; Puig-Saus, Cristina; Baselga-Carretero, Ignacio; Medina, Egmidio; Quist, Michael J; Garcia, Alejandro J; Senapedis, William; Baloglu, Erkan; Kalbasi, Anusha; Cheung-Lau, Gardenia; Berent-Maoz, Beata; Comin-Anduix, Begoña; Hu-Lieskovan, Siwen; Wang, Cun-Yu; Grasso, Catherine S; Ribas, Antoni.
Affiliation
  • Abril-Rodriguez G; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Torrejon DY; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Liu W; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Zaretsky JM; Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.
  • Nowicki TS; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA.
  • Tsoi J; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Puig-Saus C; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of California, Los Angeles, Los Angeles, USA.
  • Baselga-Carretero I; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Medina E; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Quist MJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Garcia AJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Senapedis W; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Baloglu E; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Kalbasi A; Karyopharm Therapeutics, Newton, MA, USA.
  • Cheung-Lau G; Karyopharm Therapeutics, Newton, MA, USA.
  • Berent-Maoz B; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Hu-Lieskovan S; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
  • Wang CY; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Grasso CS; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  • Ribas A; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Nat Cancer ; 1(2): 264, 2020 02.
Article in En | MEDLINE | ID: mdl-35122015
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Cancer Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Cancer Year: 2020 Type: Article Affiliation country: United States